U.S. home infusion therapy market was valued at US$ 7,849.6 million in 2018 and is estimated to reach US$ 19,250.0 million by 2027, growing at a CAGR of 10.5% over the forecast period. Major industry participants in U.S. home infusion therapy market include Baxter International, Becton Dickinson, Fresenius Kabi, Smith Medical, B. Braun, Amsino International, Halyard Health and Terumo...